ELEKTA ANNOUNCES NEW CANCER CARE SOLUTIONS AND HIGHLIGHTS PERSONALIZED EFFICIENCY AT ASTRO 2007

ELEKTA ANNOUNCES NEW CANCER CARE SOLUTIONS AND HIGHLIGHTS PERSONALIZED
EFFICIENCY AT ASTRO 2007

PRESS RELEASE	
Atlanta, Georgia, October 18, 2007


Elekta, a global leader in radiation oncology and non-invasive neurosurgery
solutions, will feature advances in cancer care at the 49th Annual Meeting of
The American Society for Therapeutic Radiology and Oncology (ASTRO) that
dramatically reduce treatment times and increase efficiency.

Elekta, a global leader in radiation oncology and non-invasive neurosurgery
solutions, will feature advances in cancer care at the 49th Annual Meeting of
The American Society for Therapeutic Radiology and Oncology (ASTRO) that
dramatically reduce treatment times and increase efficiency. 

The meeting will be held October 28 - November 1 at the Los Angeles Convention
Center (Los Angeles, California, USA). Elekta will showcase innovative offerings
that optimize productivity and workflow, empowering health care professionals to
spend more time on patient care. One important highlight will be the
announcement of a new Elekta solution for clinical Volumetric Intensity
Modulated Arc Therapy* (VMAT) that more precisely targets tumors and protects
surrounding healthy tissue, while drastically reducing radiation therapy
treatment times.

Jay Hoey, Executive Vice President Product Creation at Elekta and CEO of IMPAC
Medical Systems, an Elekta company, will unveil this improvement over existing
Intensity Modulated Radiation Therapy technologies at noon (PDT) October 28 on
Elekta booth 1719. 

Innovation on display at several Elekta Group booths

More than 11,000 domestic and international participants are expected at the
2007 ASTRO meeting. Elekta, an Ambassador-level sponsor of the event, will
feature a wide range of products from the Elekta family of companies all of
which highlight personalized efficiency.

“These Elekta innovations represent a singular focus on personalized efficiency
- optimizing every step of the care process, to ensure care is focused on the
patient and not on the technology,” says Joseph K. Jachinowski, President and
CEO, Elekta North America.

Further demonstrating its commitment to personalized efficiency, Elekta will
showcase:

• Elekta Synergy®, the market-leading multi-functional Intensity Modulated and
Image Guided Radiation Therapy (IMRT and IGRT) system that provides automated
workflow tools and 3D volumetric imaging at the time of treatment. 

• Leksell Gamma Knife® Perfexion™, the latest generation of Gamma Knife surgery
for cranial radiosurgery and the only radiation technology that has a specific
indication for the treatment of brain metastases.

• Elekta Axesse™, a whole body, robotic image-guided stereotactic treatment
management system. This cutting edge technology streamlines workflow through a
combination of advanced robotics, integrated software and patient-friendly
immobilization.

Oncology information products demonstrating personalized efficiency will be on
display at IMPAC booth 1609. MOSAIQ™, image-integrated electronic medical
record, MOSAIQ™ RTP* suite for treatment planning, the MOSAIQ™ Oncology PACS
(Picture Archiving and Communications System), an oncology specific PACS and
SYNERGISTIQ™ will be showcased. SYNERGISTIQ is a unified therapy treatment
console environment that eliminates bottlenecks associated with simultaneously
managing otherwise complex image-guidance and delivery processes.  

Medical Intelligence, an Elekta Company, also will be demonstrating advancements
in patient immobilization during radiation treatments at booth 1701. In
addition, the iBEAM® evo Couchtop - the next generation of homogenous carbon
fiber couchtops - will be on display, as well as, the new fully robotic HexaPOD™
evo** positioning table for efficient and accurate 6D patient positioning. 

These and other Elekta solutions demonstrate Elekta's commitment to making
cancer care easier for therapists and patients. “The combination of Elekta and
IMPAC clinical solutions are simplifying and streamlining the treatment process
to create a better experience for patients, as well as, enhance the efficiency
of the clinician, demonstrating our commitment to personalized efficiency,” says
Jachinowski. 

Users' Meeting 

Concurrent with the ASTRO show will be the IMPAC and Elekta Radiation Oncology
Users' Meeting, Saturday, October 27 at the Pasadena Civic Center (Pasadena,
California, USA). Expected to draw more than 1,000 IMPAC and Elekta users, the
meeting will focus on optimizing personalized efficiency within the clinic
through advanced and dynamic innovations. Participants will attend sessions on
EMR workflow featuring MOSAIQ, efficiency and advancements in IGRT and
stereotaxy, and business and economic solutions.

******


*Volumetric Intensity Modulated Arc Therapy (VMAT) and MOSAIQ™ RTP are works in
progress and not commercially available 
**HexaPOD™ evo is pending 510(k) clearance from the FDA

For further information, please contact:

Media inquiries: Michelle Lee, PR and Advertising Manager, Tel: +1 770-670-2447,

e-mail: michelle.lee@elekta.com
Global Marketing inquiries: Peter Gaccione, Vice President, Global Marketing,
Tel:  +1 770-670-2380,  
e-mail: peter.gaccione@elekta.com
Investor inquiries: Peter Ejemyr, Group VP Corporate Communications, Tel: +46
733 611 000 (mobile), 
e-mail: peter.ejemyr@elekta.com

About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 4,500 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.